🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the long-term safety and tolerability of idalopirdine (Lu AE580...
Status
Completed
Location
US027
Start Date
2014-04-07
Trial ID
NCT02079246
Treatments Being Tested
This study aims to establish bioequivalence between two tablet formulations...
Status
Completed
Location
Covance
Start Date
2015-03
Trial ID
NCT02371707
Treatments Being Tested
To evaluate the effect of idalopirdine (120 and 360 mg) on cardiac repolari...
Status
Completed
Location
FR801
Start Date
2015-05
Trial ID
NCT02436486
Treatments Being Tested
The purpose of this study is to investigate whether 2 different tablet comp...
Status
Withdrawn
Location
GB1050
Start Date
2016-09
Trial ID
NCT02894515
Treatments Being Tested
To investigate the brain receptor occupancy of idalopirdine in patients wit...
Status
Terminated
Location
Johns Hopkins Hospital
Start Date
2017-09-22
Trial ID
NCT03307993
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics properties of...
Status
Completed
Location
DE801
Start Date
2015-01
Trial ID
NCT02340195
Treatments Being Tested
To establish efficacy of Idalopirdine as adjunctive therapy to donepezil fo...
Status
Completed
Location
US338
Start Date
2014-02
Trial ID
NCT02006641
Treatments Being Tested
The purpose of this study is to investigating the absorption, metabolism an...
Status
Completed
Location
GB802
Start Date
2015-04
Trial ID
NCT02415907
Treatments Being Tested
To establish efficacy of idalopirdine as adjunctive therapy to donepezil fo...
Status
Completed
Location
US027
Start Date
2013-10
Trial ID
NCT01955161
Treatments Being Tested
To establish efficacy of idalopirdine as adjunctive therapy to acetylcholin...
Status
Completed
Location
US612
Start Date
2014-03
Trial ID
NCT02006654
Treatments Being Tested